KALA BIO

KALA

Market cap $12.3M

KALA Hedge Fund Activity: Q1 2026 in Review

28 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2026, worth a combined $294K — down 81% from $1.58M a quarter earlier.

Fund positioning in KALA was balanced in Q1 2026: 9 funds opened new positions, 9 closed out, 8 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $159K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1M sold.

• 28 institutional investors held KALA BIO (KALA) as of Q1 2026, down from 29 in Q4 2025.
• Funds reported $294K of KALA BIO stock for Q1 2026, down 81% quarter-over-quarter.
• 9 funds opened new KALA BIO positions in Q1 2026 and 9 closed out, a net change of 0 holders.
• The largest KALA BIO buyer in Q1 2026 was Renaissance Technologies, an estimated $159K added.
• The largest KALA BIO seller in Q1 2026 was Baker Bros. Advisors, an estimated $1M sold.

Based on aggregated 13F filings for Q1 2026.